HAP-1 is a potent inhibitor widely used in biomedicine for cancer research. It targets specific signaling pathways, offering a promising approach for treating various types of cancers, including breast, lung, and prostate. HAP-1's effective suppression of tumor growth makes it a valuable tool for studying cancer progression and exploring potential therapeutic interventions.
CAT# | GR2215 |
CAS | 329004-38-8 |
M.F/Formula | C60H90N18O17 |
M.W/Mr. | 1335.47 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Myristoyl hexapeptide-4, a stabilized peptide, is a synthetic peptide containing lysine, threonine and serine re ...
Gonadorelin acetate, a synthetic decapeptide with sequence Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2, is a gon ...
DAPTA (D-[Ala]-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-amide), D-Ala-Peptide T amide, is one of analogue of peptide T, which ...
Basic information Desmopressin is a synthetic analogue of the antidiuretic hormone vasopressin used in the treatment of centr ...
Abarelix, sold under the brand name Plenaxis, is a synthetic decapeptide and Gonadotropin-releasing hormone (GnR ...